1[1]Held ph. Yusufs.Effects of β-blockers and calcium channel blockers in acute myocardial infarction. Eur Heart J,1993,14(Suppl F):18～25.
2[2]The CAPRICORN investigators. Effect of Carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction:the CAPRICORN randomized trial. Lancet, 2001,357:1651～1658.
3[3]Kennedy HL,Brooks MM,Barker AH, et al.Beta-blocker therapy in the cardiac arrhythmia suppression trial.Am J Cardiol,1994,76:674～680.
4[4]Pfeffer MA,Braunwald E,Moye LA,et al.Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction.N Eng J Med,1992,327:685～691.
5[5]Kober L,torp-Pederson C,Carlsen JE, et al.A clinical trial of the angiotensin-corverting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction.N Engl J Med,1995,333:1670～1676.
6[6]Cooper AH,Dries Dl,Davis CE,et al.Diuretics and risk of arrhythmic death in patients with left ventricullar dsyfunction. Circulation,1999,100:1311～1315.
7[7]Zannad F,Alla F,Dousset B,et al.Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure. Circulation,2000,102:2700～2706.
8[8]Amiodarone trials meta-analysis investigators.Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure:meta-analysis of individual data from 6500 patients in randomized trial. Lancet,1997,350:1417～24.
9[9]The Antiarrhythmics Versus Implantable Defibrillators(AVID) investigators.A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med,1997,337:1576～83.
10[10]Connolly SJ,Gent M,Roberts RS,et al.Canadian implantable defibrillator study (CIDS):a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation,2000,101:1297～1302.
